This volume investigates the systemic challenges and practical applications of economic appraisal methods when evaluating new health technologies within the European Community. Michael F. Drummond, a recognized expert in health economics, synthesizes research to address how economic evaluation can inform the development, diffusion, and clinical implementation of medical innovations. The text provides a framework for integrating cost-effectiveness analysis into biomedical engineering, clinical research, and national health budgetary planning.

Experts identify this work as a foundational text for understanding the intersection of health economics and policy within the European context. Readers frequently note the technical density of the prose, which is tailored for professionals in health services research and public policy administration.